Tag Archives: Walgreens

AllianceRx Walgreens Prime Dispensing Arcalyst and Gavreto

AllianceRx Walgreens Prime (AllianceRx) is offering Arcalyst (rilonacept) and Gavreto (pralsetinib), two medicines prescribed for the treatment of specific kinds of cancer as well as an autoinflammatory cardiovascular disease

Walgreens Investing in Future Growth of Health System Specialty Pharmacies

Walgreens Boots Alliance (WBA) and Shields Health Solutions announced that WBA, through its wholly-owned subsidiary, Walgreen Co., is making a majority investment in Shields, an industry leader in integrated, health system-owned specialty pharmacy care

NUZYRA Continues to be the Primary Driver for Paratek Pharmaceuticals’ Growth

The FDA approved Paratek’s supplemental New Drug Application (sNDA) for the oral-only dosing regimen of NUZYRA® for the treatment of adults with Community-Acquired Bacterial Pneumonia (CABP)

AllianceRx Walgreens Prime Expanding Digital Clinical Capabilities with Highmark

AllianceRx Walgreens Prime’s digital clinical assessments are available for patients with chronic inflammatory disease, multiple sclerosis, cystic fibrosis, idiopathic pulmonary fibrosis, organ transplants, lipid and blood disorders

Humana Joins Cigna’s Drug Buying Group Ascent Health Services

Ascent Health manages commercial rebates, the payments that drug makers make to health plans

RxSense Joins with Hy-Vee to Launch New PBM Vivid Clear Rx

RxSense will provide Vivid Clear Rx, food and drug retailer Hy-Vee’s new PBM, with modules that will supplement existing Hy-Vee health care assets

MyWalgreens Revamped to Accelerate the Company’s Digital Transformation

Walgreens interacts with approximately 8 million customers in its stores and online each day and has more than 90 million Balance Rewards members

AllianceRx Walgreens Prime Aggressively Increasing Digital Capabilities

AllianceRx is continuing to taking steps to help patients with chronic or complex conditions better manage their care online